Meet us at upcoming conferences!
Berlin, Germany, 15-17 May 2024
ESMO Breast Cancer 2024
Schedule a meeting with:
Helle Fisker, VP Commercial
Chicago, IL, USA, May 31 - June 4, 2024
ASCO Annual Meeting 2024
“The Art and Science of Cancer Care: From Comfort to Cure.” – ASCO Annual Meeting 2024
Schedule a meeting with:
The American sales team at marketing@biovica.com
Rotterdam, Netherlands, 10-13 June, 2024
EACR 2024 Congress
EACR 2024 Congress: Innovative Cancer Science – EACR 2024 Congress
Schedule a meeting with:
Hanna Ritzén, COO
Mattias Bergqvist, Clinical Development Director
Barcelona, Spain, 13-17 Sep 2024
ESMO Congress 2024
Schedule a meeting with:
Helle Fisker, VP Commercial
Recent events
San Diego, California, USA, 5-10 April 2024
AACR Annual Meeting 2024
San Antonio, Texas, USA, 5-9 December 2023
SABCS
Amy Williams, Head of Clinical Development and Medical Affairs, Biovica at the San Antonio Breast Cancer Symposium (SABCS) 2023 – sabcs.org.
Lisbon, Portugal, 9-11 November 2023
ABC 7
Biovica COO Hanna Ritzén presenting our poster at Advanced Breast Cancer Seventh International Consensus Conference – abc-lisbon.org
Uppsala, Sweden, 26-27 October 2023
SOTA Breast Cancer Conference
Helle Fisker, VP Commercial, and Caroline Korsbæk Nørby, Marketing Assistant, at the Biovica booth with poster: ‘Next-level cancer monitoring with: First and only FDA-cleared blood test for TKa in HR+ Stage IV BC’.
Chicago, IL, USA, 2-6 June 2023
ASCO Annual Meeting
A poster with DiviTum® TKa results from the SWOG study S0226 was presented on Sunday, June 4.
conferences.asco.org
Berlin, Germany, 11-13 May 2023
ESMO Breast Cancer
Grazia Arpino, MD, PhD, Professor, at University of Naples Federico II, with Biovica’s Helle Fisker, VP, in front of poster “Correlation of circulating tumor DNA (ctDNA) or Thymidine Kinase activity (TKa) Dynamic Patterns with tumor response…in BioItaLEE trial!”
ESMO Breast Cancer
Orlando, Florida, USA, 14-19 April 2023
AACR Annual Meeting
Mattias Bergqvist, Clinical Development Director, and Hanna Ritzén, VP of R&D, at Biovica’s poster in Orlando.
aacr.org
Kalmar, Sweden, 21-23 March 2023
Swedish Oncology Days
The Biovica booth at Onkologidagarna 2023 with poster: Next-level cancer monitoring with: First and only FDA-cleared blood test for TKa in HR+ Stage IV BC.
onkologidagarna.se